[Combination therapy of antibiotics and intravenous immunoglobulin]

Nihon Rinsho. 2001 Apr;59(4):781-4.
[Article in Japanese]

Abstract

A large scale multicenter randomized controlled study was conducted to evaluate the efficacy of intravenous immunoglobulin in combination with IPM/CS and AMK in 504 evaluable patients who did not respond by 3 day therapy with beta-lactum and aminoglucoside. Immunoglobulin 5 g was administered 3 days to the patients allocated to immunoglobulin group. A completely automatic computer evaluation was performed according to the criteria determined by the committee. The response rate was 61.5% in immunoglobulin group and 47.3% in control group(p < 0.001). Intravenous immunoglobulin is considered effective for severe infection when used as combination therapy with antibiotics.

Publication types

  • Clinical Trial
  • English Abstract
  • Randomized Controlled Trial

MeSH terms

  • Amikacin / administration & dosage*
  • Anti-Bacterial Agents / administration & dosage*
  • Bacterial Infections / drug therapy
  • Cilastatin / administration & dosage*
  • Drug Therapy, Combination / administration & dosage*
  • Humans
  • Imipenem / administration & dosage*
  • Immunoglobulins, Intravenous / administration & dosage*
  • Multicenter Studies as Topic
  • Protease Inhibitors / administration & dosage*
  • Randomized Controlled Trials as Topic
  • Thienamycins / administration & dosage*

Substances

  • Anti-Bacterial Agents
  • Immunoglobulins, Intravenous
  • Protease Inhibitors
  • Thienamycins
  • Cilastatin
  • Imipenem
  • Amikacin